Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients.

NCT01120093 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Aclidinium bromide 100 μg bid
DRUG: Aclidinium bromide 200 μg bid
DRUG: Aclidininum bromide 400 μg bid
DRUG: Placebo
DRUG: Formoterol 12 μg bid

Sponsor

AstraZeneca